Maritza Pupo Antunez

Title: Maritza Pupo Antunez: Innovator in Dengue Virus Research

Introduction

Maritza Pupo Antunez is a notable inventor based in Havana, Cuba. She has made significant contributions to the field of virology, particularly in the study of the dengue virus. Her innovative work has led to the development of synthetic peptides that play a crucial role in understanding and combating this viral infection.

Latest Patents

Maritza holds a patent titled "Pre-M/M epitopes of dengue virus, synthetic peptides, chimeric proteins and their use." This invention relates to five synthetic peptides of the pre-M/M protein of the Dengue-2 virus, corresponding to specific amino acid sequences. The anti-peptide immune response was evaluated in mice, demonstrating the potential of these peptides in eliciting neutralizing antibodies against all four serotypes of the dengue virus. The research highlights the presence of B cell epitopes in both mice and humans, showcasing the relevance of these peptides in the immune response against the flavivirus.

Career Highlights

Throughout her career, Maritza has focused on innovative research that bridges the gap between basic science and practical applications in medicine. Her work has not only advanced the understanding of dengue virus immunology but has also paved the way for potential vaccine development.

Collaborations

Maritza has collaborated with esteemed colleagues such as Susana Vazquez Ramudo and Guadalupe Guzman Tirado. These partnerships have enriched her research and contributed to the success of her innovative projects.

Conclusion

Maritza Pupo Antunez exemplifies the spirit of innovation in the field of virology. Her contributions to dengue virus research through her patented work are invaluable in the ongoing fight against this disease.